Here’s Who Just Picked Up Westport Fuel Systems Inc. (NASDAQ:WPRT) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Westport Fuel Systems Inc. (NASDAQ:WPRT) reported that Yu Peter has picked up 8,064,516 of common stock as of 2017-04-04.
The acquisition brings the aggregate amount owned by Yu Peter to a total of 8,064,516 representing a 7.33% stake in the company.
For those not familiar with the company, Westport Fuel Systems Inc (Westport), formerly Westport Innovations Inc, is a Canada-based provider of low-emission engine and fuel system technologies utilizing gaseous fuels. It operates through the Westport Operations segment. The Westport Operations segment designs, manufactures and sells compressed natural gas, liquefied natural gas, and liquefied petroleum gas components and systems to original equipment manufacturers and to aftermarket customers. Westport’s subsidiaries design and manufacture a range of components, including pressure regulators, injectors, electronic control units, valves and filters; sell monofuel, bi-fuel and dual-fuel diesel blend conversion kits, and also offer full engine management systems and solutions. The Westport Operations segment has a customer base in Europe and North America, as well as in Asia, South America, and Africa. Westport supports customers with natural gas and propane vehicle conversions through the Ford QVM program for Ford vehicles.
A glance at Westport Fuel Systems Inc. (NASDAQ:WPRT)’s key stats reveals a current market capitalization of 119.03 Million based on 109.39 Million shares outstanding and a price at last close of $1.10 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-05-11, Douglas picked up 15,068 at a purchase price of $6.02. This brings their total holding to 1,061,846 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Westport Fuel Systems Inc. (NASDAQ:WPRT) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Catch Peregrine Pharmaceuticals (NASDAQ:PPHM) Shares on This Pullback
Peregrine Pharmaceuticals (NASDAQ:PPHM) shares dipped 2.60% on Monday to $0.637 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.28 to $0.77. The company has a market cap of $184.75 million at 297.71 million shares outstanding.
Peregrine Pharmaceuticals is a biopharmaceutical company that operates through two segments: Peregrine, which is engaged in the research and development of monoclonal antibodies for the treatment of cancer, and Avid, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts.
Bavituximab, which is its lead immunotherapy candidate, is a monoclonal antibody that targets and binds to phosphatidylserine (PS), a immunosuppressive molecule that is usually located inside the membrane of healthy cells, but then flips and becomes exposed on the outside of cells in the tumor microenvironment, causing the tumor to evade immune detection. The company’s subsidiary is Avid Bioservices, Inc. (Avid). Avid provides integrated current good manufacturing practices (cGMP) services from cell line development to commercial biomanufacturing.
In a press release, Peregrine Pharmaceuticals announced the presentation of positive new data from the company’s ongoing collaboration with researchers from Memorial Sloan Kettering Cancer Center. This will highlight the phosphatidylserine (PS)-targeting antibodies to enhance the anti-tumor activity of adoptive T cell transfer therapy without triggering any off-target toxicities.
While adoptive T cell transfer remains one of the most exciting new approaches to treating cancer, to date the toxicity associated with the treatment has limited its potential. We are encouraged that these study results showed that the combination of anti-PS and adoptive T cell treatment led to enhanced anti-tumor effect without any evidence of additional off-target side effects,” said Taha Merghoub, Ph.D., co-director of the Ludwig Collaborative Laboratory at MSK. “We believe that these findings may support potential applications for this combination in solid tumors in the future.”
Cancer immunotherapy thought-leaders, Taha Merghoub, Ph.D. and Jedd D. Wolchok, M.D., Ph.D., evaluated and compared the anti-tumor activity and off-target toxicities of adoptive T cell transfer therapy in combination with either PS-targeting antibodies. Additional study results demonstrated that the PS-targeting antibodies decreased tumor-induced immunosuppression as evidenced by a decrease in immunosuppressive regulatory T cells (Tregs) and M2 macrophages, consistent with Peregrine Pharmaceuticals belief that bavituximab may modulate the immunosuppressive tumor microenvironment and enhance the activity of immunotherapy agents.
These study results provide further support for our belief that anti-PS agents such as bavituximab can play an important role as part of combination cancer treatments. This is directly tied to the agents’ ability to modulate the tumor microenvironment to combat the immunosuppression that limits the activity of CAR T and immunotherapies,” said Joseph Shan, vice president of clinical and regulatory affairs at Peregrine Pharmaceuticals.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.
Fisher Doris F picked up Gap Inc (NYSE:GPS) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Gap Inc (NYSE:GPS)
reported that Fisher Doris F has picked up 25,787,331 of common stock as of 2017-04-03.
The acquisition brings the aggregate amount owned by Fisher Doris F to a total of 25,787,331 representing a 6.4% stake in the company.
For those not familiar with the company, The Gap, Inc. (Gap Inc.) is an apparel retail company. The Company offers apparel, accessories and personal care products for men, women and children under the Gap, Banana Republic, Old Navy, Athleta and Intermix brands. Its products are available to customers online through Company-owned Websites and through the use of third-parties that provide logistics and fulfillment services. It also sells products that are designed and manufactured by branded third-parties, especially at its Intermix brands. The Company’s segments include Gap Global, Old Navy Global, Banana Republic Global, Athleta and Intermix. Its omni-channel services, including order-in-store, reserve-in-store, find-in-store and ship-from-store are tailored across its portfolio of brands. Gap Inc. The Company has Company-operated stores in the United States, Canada, the United Kingdom, France, Ireland, Japan, Italy, China, Taiwan and Hong Kong.
A glance at Gap Inc (NYSE:GPS) ’s key stats reveals a current market capitalization of 9.42 Million based on 399.84 Million shares outstanding and a price at last close of $23.71 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-11-23, Peck picked up 37,150 at a purchase price of $26.99. This brings their total holding to 37,150 as of the date of the filing.
On the sell side, the most recent transaction saw Fisher unload 17,279 shares at a sale price of $24.58. This brings their total holding to 8,850,449.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Gap Inc (NYSE:GPS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.